AI analysis of CT scans finds coronary inflammation in 42.9% of patients
| Source: HN | Original article
AI analysis of heart CT scans at a preventive‑health clinic identified coronary inflammation in 42.9% of patients.
A private preventive‑health clinic, Biograph, has completed its first U.S. study using Caristo Diagnostics’ CaRi‑Heart artificial‑intelligence platform to analyse coronary CT scans. The AI‑driven assessment identified elevated coronary inflammation in 42.9 % of the participants – adults who were otherwise deemed low‑risk and asymptomatic. A further 17.9 % showed very high inflammation in at least one major artery. Conventional blood markers and the standard risk‑calculator tools failed to flag any of these cases.
The findings raise questions about the adequacy of current cardiovascular‑risk screening, which relies heavily on blood tests and demographic risk scores. If AI can reliably surface hidden arterial inflammation, clinicians may gain a tool for earlier intervention, potentially reshaping preventive‑cardiology pathways. However, the study stops short of proving that the detected inflammation predicts future cardiac events, a gap that regulators and insurers are likely to scrutinise before endorsing widespread adoption.
Watch for follow‑up research that links AI‑measured inflammation to hard outcomes such as heart attacks or strokes. Longitudinal studies, larger and more diverse cohorts, and head‑to‑head comparisons with established imaging biomarkers will be crucial to validate the clinical utility of CaRi‑Heart. Industry observers will also monitor whether health systems integrate the technology into routine cardiac CT protocols and how payer policies evolve around AI‑augmented diagnostics. The next few months should reveal whether this early‑detection promise translates into actionable, evidence‑based practice.
Sources
Back to AIPULSEN